- The Law
Welcome to My Meds Matter
Major concern about committee recommendation for Beyond-Use-Dating
New rule would cut access to compounds in California, Increase costs
H.R. 2871, The Preserving Patient Access to Compounded Medications Act of 2017
NCPA supports Congress's efforts to assure appropriate oversight of compounding pharmacies in a way that does not curtail or hinder patient access to those specially-tailored medications.
A bipartisan effort to preserve patient access to vital compounded medications.
The International Academy of Compounding Pharmacists (IACP) strongly supports new legislation HR 2871 – The Preserving Patient Access to Compounded Medications Act of 2017
Committee Demands Radical Policy Revisions
House Appropriations Committee says FDA policies go against Congressional intent
Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations
Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act
Proposed policy lays out new rules for veterinarians
The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.
No front page content has been created yet.